Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Net income (loss) $ (42,674) $ 46,167
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 23,177 23,011
Amortization of debt discount and debt issuance costs 1,924 2,056
Net loss on sales and disposals of assets 73 83
Stock-based compensation expense 2,506 2,175
Goodwill impairment 1,092  
Write down of long-lived assets 4,234  
Settlement gain on benefit plan (1,675)  
Change in deferred income taxes 838 379
Change in operating assets (18,656) 18,438
Change in operating liabilities 2,520 (42,517)
Other 17 1,197
Net cash provided by (used in) operating activities (26,624) 50,989
Investing activities:    
Capital expenditures (30,343) (20,105)
Acquisition, net of cash received   (11,584)
Net cash used in investing activities (30,343) (31,689)
Financing activities:    
Proceeds from issuance of debt 15,825  
Deferred acquisition payments (6,617)  
Payments of long-term debt (1,576) (4,084)
Net borrowings (payments) under other credit facilities   (3,153)
Proceeds from exercise of stock options 42 159
Debt issuance costs (275) (29)
Change in restricted cash   (36,497)
Net cash provided by (used in) financing activities 7,399 (43,604)
Net decrease in cash and cash equivalents (49,568) (24,304)
Effect of foreign currency fluctuations on cash (458) (584)
Cash and cash equivalents at beginning of fiscal period 210,521 152,051
Cash and cash equivalents at end of fiscal period $ 160,495 $ 127,163